Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yining Pills (怡宁丸) is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Beijing Hospital of Traditional Chinese Medicine, affiliated with Capital Medical University. It is specifically indicated for the treatment of chronic insomnia, particularly cases associated with TCM patterns such as heart-spleen deficiency or liver-qi stagnation. The formulation is a complex mixture of herbs, including *Ziziphus jujuba* var. *spinosa* (Suan Zao Ren), *Poria cocos* (Fu Ling), and *Polygala tenuifolia* (Yuan Zhi), which are traditionally used to nourish the heart, calm the spirit (Anshen), and regulate the flow of Qi. As a hospital-made preparation (院内制剂), its clinical use is generally restricted to the developing institution and its medical network under specific regulatory approvals for TCM hospital formulas in China. It is recognized for its ability to improve sleep latency and quality with a favorable safety profile compared to synthetic sedative-hypnotics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yining Pills.